A director of the government’s innovation agency has resigned over “unreconciliable difference in values” and called for investigations into evidence of wrongdoing uncovered in recent months.
Rachel Kelly, co-CEO of biotech startup Taylored Technologies, announced her resignation on LinkedIn, writing that she had “experienced serious conflict over my values and the decisions made by the board, namely regarding the things we learned during recent due diligence activities and subsequent OIAs”.
That investigation had shed light on behaviour by “other businesses with serious implications that, in my opinion, shouldn’t be tolerated or at the very least…investigated by the correct authorities”.
“I’m choosing not to sit back and do nothing when I see bullies continue to bully,” she added.
Kelly did not make any specific allegations, but wrote that she wanted “a light to be shone very brightly on the truth of this situation”.
“I want good people/organisations who got caught in the middle of this situation to be given safe passage through,” she wrote, and “I want any villains and allegations of this situation to be graciously exposed, with proof of what they’ve done, and justice for their victims.”
Callaghan Innovation is a Crown agency tasked with supporting the commercialisation of science, engineering, technology and design in New Zealand. It is named after the late Sir Paul Callaghan, who championed the role of science in New Zealand’s economic success.